Under the agreement, Ana Darou gained exclusive rights to market and sell Nalox/Emtrix in Iran while Moberg assumes production and supply responsibility.
Moberg Derma CEO and founder Peter Wolpert said the agreement is part of the company’s international commercialization of Nalox/Emtrix.
"We are looking forward to make the product available to the patients in Iran through the cooperation with Ana Darou," Wolpert added.
Nalox is a prescription free, over-the-counter product sold under the name Emtrix in certain markets and under the name Kerasal Nail in the US.